Introduction
Retinoic acid (RA), a natural derivative of vitamin A, exhibits regulatory properties on growth and differentiation of many vertebrate tissues (De Luca, 1991; Chambon, 1994; Gudas et al., 1994; Hofman and Eichele, 1994) . The RA actions are believed to be primarily mediated by retinoic acid receptors (RAR a, b and g) and retinoid X receptors (RXR a, b and g), which belong to the nuclear hormone receptor superfamily (Leid et al., 1992a; Chambon, 1994; GigueÁ re, 1994; Gronemeyer and Laudet, 1995; Mangelsdorf and Evans, 1995) . The RARs and RXRs display the modular structure of nuclear receptors with six distinct regions (denoted A ± F) comprising the region C or DNA-binding domain (DBD) and the region E, which mediates ligand binding, ligand dependent transcriptional activation by AF-2 (Durand et al., 1994) and dimerization (Forman and Samuels, 1990; Leid et al., 1992b; Glass, 1994; Chambon, 1996) .
RARs bind and are activated by all-trans RA and its 9-cis isomer (Zelent et al., 1989; Allenby et al., 1993) , while RXRs bind and are activated by 9-cis RA only Levin et al., 1992; Mangelsdorf et al., 1992) . Transcriptional activation through retinoic acid response elements is thought to be mediated by heterodimer formation between RAR and RXR family members, or by homodimer formation of RXRs (Leid et al., 1992a; Zhang et al., 1992; Heery et al., 1993; GigueÁ re, 1994; Glass, 1994) . These various RXR-RAR and RXR-RXR combinations within the cell could explain the diversity of RA eects. Moreover, RXRs not only serve as accessory factors for RARs in retinoid signaling, but also function as DNA binding partners for thyroid hormone receptors (TRs), the vitamin D3 receptor (VDR), peroxisome proliferator activated receptors (PPARs) and numerous orphan receptors (Chambon, 1994; GigueÁ re, 1994; Glass, 1994; Leblanc and Stunnenberg, 1995; Mangelsdorf and Evans, 1995) . Thus RXRs are considered to play a central role in the mediation of several hormonal signals.
The C2 myogenic cell line is a well established model system for the study of retinoid receptor functions in the control of proliferation and dierentiation. We previously reported that RA promotes growth arrest and myogenesis of C2 myoblasts (Albagli-Curiel et al., 1993) . Furthermore, RA regulates the expression of some myogenic factors (members of MyoD family) involved in the activation of the myogenic program (Albagli-Curiel et al., 1993; Carnac et al., 1993a,b) . Finally, the study of a C2 subclone which failed to respond to RA has revealed an essential role of RXRa in mediating RA-induced growth arrest and control of gene expression in those cells (FroeschleÂ et al., 1996) . However, as RARs and RXRs coexist in C2 cells, it is dicult to establish a speci®c role for each receptor in the RA signaling pathway (Carnac et al., 1993a; Downes et al., 1994) . To determine the speci®c role played by each RAR or RXR family in regulating cell growth and dierentiation of C2 cells, we have now compared the eect of RA in C2 myoblasts expressing a dominant negative RAR (dnRAR) lacking the ligand-dependent transcriptional activation function of RARa or a dominant negative RXR (dnRXR) lacking the DNA binding domain of RXRb. Our results show that the RA-induced growth arrest and dierentiation are delayed in C2 cells expressing dnRAR or dnRXR. Furthermore, this eect is more pronounced in C2-dnRXR myoblasts. We also demonstrate that the expression of several RAresponsive genes is impaired in these two types of C2 cell lines. Interestingly, we report that RA-induced expression of the MyoD gene is lost in C2-dnRXR but not in C2-dnRAR cells, which indicates some speci®city of RAR and RXR families function in myogenic cells. Finally, using C2 sublines which dier in their pattern of retinoid responsiveness, we provided additional evidence of a link between the RXR and MyoD families in mediating RA myogenic events. These results illustrate the contribution of MyoD and RXR families to muscle cell dierentiation.
Results
Overexpressed dnRAR or dnRXR acts as dominant negative inhibitor of RA-induced reporter transcription in C2 myoblasts Previous studies of Durand et al. (1992) and Minucci et al. (1994) respectively described the mutated RARa lacking the ligand-dependent transcription activation function (AF-2
7
) and the mutated RXRb lacking the DNA binding domain (DBD
) which exert a dominant negative activity in P19 embryonal carcinoma cells. Before using these mutant receptors (designated in this work as dnRAR and dnRXR) to block the action of endogenous retinoic acid receptors in myogenesis, we ®rst tested their dominant negative activity following transient transfection into C2 myogenic cells. For this purpose, C2 cells were cotransfected with the expression vectors encoding dnRAR or dnRXR receptors (pSG5-dnRAR or pSG5-dnRXR) and a reporter construct containing the classical retinoic-acid response element (RAREb) (de TheÂ et al., 1990; Homan et al., 1990) in front of the thymidine kinase promoter linked to the chloramphenicol-acetyl transferase gene (tk-CAT) (see Materials and methods) ( Figure 1 ). As shown in Figure 1 , treatment of pSG5-transfected C2 cells with RA increased RAREb-tk-CAT reporter activity by 2 ± 3-fold. However, when dnRAR or dnRXR was cotransfected, CAT activity was strongly inhibited (maximum inhibition =100%).
These results indicate that both types of mutated RA-receptors inhibited RA-induced activation of reporter transcription, consistent with the proposed dominant-negative properties Minucci et al., 1994) . This inhibition is likely to be attributed to impaired function of endogenous RAreceptors through formation of nonfunctional RAR/ RXR heterodimers.
Overexpressed dnRAR or dnRXR inhibits the RA-induced growth arrest in C2 myoblasts
The eectiveness of the dnRAR or dnRXR in inhibiting the transcriptional activation of endogenous RA-receptors in C2 cells prompted us to explore their ability to disturb the action of endogenous RAreceptors in mediating RA myogenic eects.
A characteristic of RA-treated C2 cells is a marked slowing of cellular growth as dierentiation progresses. Here, we have tested whether the expression of dominant negative RA-receptors alters the normal RA responsiveness of C2 cells with respect to growth arrest. C2 cells were cotransfected with the expression vectors encoding dnRAR or dnRXR receptors together with pSV2neo as selection marker. Control cells were cotransfected with pSG5 plasmid without insert plus pSV2neo. Cells in proliferation medium (see Materials and methods) were selected by G418 alone, or by G418 plus RA (10 76 M), during a 2 ± 3 weeks period. At the end of the culture, colonies were stained with Giemsa stain and counted (Figure 2 ). When selected by G418 alone, a large number of colonies (100 ± 150) were produced by transfection with the dominant-negative receptors or the control plasmid. However, when selected by the G418 plus RA, only a few colonies emerged by transfection with the control plasmid. In contrast, transfection with dnRAR or dnRXR resulted in a larger number of colonies surviving the selection (RA+G418). Note that the number of RA-resistant cells is greater in dnRXR than in dnRAR transfected cells (Figure 2 ). These results were observed reproducibly in three separate experiments. These data demonstrate that C2 myoblasts expressing dnRAR or dnRXR fail to arrest cell growth in response to RA. It is interesting to note that, in absence of RA, mutated receptors reduced the proliferative capacity of C2 cells, a result also obtained with C2 cells overexpressing intact RAR or RXR (Figure 2 and data not shown). This observation could be explained by the ligandindependent transactivation function (AF-1) contained within the A/B region of these wild type and mutated retinoic acid receptors (Nagpal et al., 1992 (Nagpal et al., , 1993 . These results demonstrate that in C2 cells expression of dnRAR or dnRXR leads to inhibition of RAinduced growth arrest.
Overexpressed dnRAR or dnRXR delays the RA-induced dierentiation in C2 myoblasts
To further investigate the impact of the dominantnegative RA-receptors eects on the RA-induced dierentiation process, we established stably dnRARor dnRXR-expressing C2 cells by cotransfecting expression vectors encoding either dnRAR or dnRXR together with the pSV2neo as described above (see Materials and methods). Several stably transfected cell populations were selected and characterized. These cell populations designated C2-dnRAR and C2-dnRXR expressed dierent levels of dnRAR or dnRXR transcripts which were, as expected, undetectable in C2-neo cells (Figure 3a) . It is of note that levels of dominant negative receptor transcripts in the selected cell populations were comparable to the level of the endogenous corresponding receptor.
We then examined the dierentiation response of these dierent stably transfected C2 cell populations to RA. Among the four cell populations tested, the RAinduced dierentiation of representative C2-dnRAR1 and C2-dnRXR1 cell populations was evaluated by immuno¯uorescence analysis. Myoblasts were induced to dierentiate in low serum medium supplemented with RA (10 76 M) during 3 days (see legend Figure 3b ), then immunostained for troponin T, a late muscle marker. The control C2-neo cells exhibited a similar response to RA as detailed previously for the parental C2 cells with 65% of the cultured cells undergoing dierentiation after 3 days of RA-treatment (FroeschleÂ et al., 1996) . In contrast, the dominant negative receptors transfected C2 cell populations exhibited marked blunting of this dierentiative response to RA with no more than 10 ± 18% of the cells dierentiated after exposure to RA. Note that C2-dnRXR1 cell dierentiation seems to be twofold more resistant to RA than C2-dnRAR1 dierentiation. Similar results were obtained for C2-dnRAR2 and C2-dnRXR2 cells (data not shown). Thus, the overexpression of dominant negative RA-receptors delays the RA-induced dierentiation process in C2 cells.
Overexpressed dnRAR or dnRXR results in impaired RA-induction of several genes during myogenic dierentiation
Both C2-dnRAR1 and C2-dnRXR1 cell populations were investigated in detail to assess their ability to dierentiate in response to RA, as measured by the expression of RA-responsive genes. The two dominantnegative C2 cell populations and the C2-neo control cell line were treated or not with 10 76 M RA and the dierentiation was monitored by Northern blot analysis ( Figure 4 ). The expression of three genes known to be regulated by RA in C2 cells, namely RARb, MyoD and myogenin was compared in the three stable transfectants.
In various cell types including the C2 cell line, expression of RARb is induced following RAtreatment (Albagli-Curiel et al., 1993; Carnac et al., 1993b) . Furthermore, the RAREb response element has been described and characterized in the regulatory region of RARb gene (de TheÂ et al., 1990; Homan et al., 1990) . In C2-neo control cells, RARb mRNA was undetectable before RA-treatment but was strongly
Figure 2 dnRAR and dnRXR antagonize the RA-induced growth arrest in C2 cells. C2 cells were co-transfected with pSV2neo and the indicated plasmids and were selected by G418 in the presence (+RA) or absence (7RA) of 10 76 M RA for 2 weeks. Plates (100 mm in diameter) were ®xed and stained with Giemsa stain. Representative colony formation assay and graph corresponding to several independent experiments are shown RARs and RXRs functional specificity in C2 cells S Alric et al induced by 6 h of treatment ( Figure 4 ). In contrast, in both dominant-negative transfectants, RARb mRNA was not RA-inducible, consistent with the transient transfection data in parental C2 cells (see Figure 1 ). These results indicate that the RA-induction of RARb gene is abolished by the expression of mutant RAR or RXR receptors consistent with the report of that RA transcriptional activation of RARb gene is mediated by RAR-RXR heterodimers.
We next compared the RA-regulation of MyoD and myogenin gene expression over a time course period of RA treatment for C2-neo, C2-dnRAR1 and C2-dnRXR1 cells. In C2 cells, MyoD is constitutively expressed at the myoblast stage while myogenin only appears at dierentiated stage (Montarras et al., 1989) . It has been documented that both MyoD and myogenin genes are upregulated in response to RA in C2 cells (Albagli-Curiel et al., 1993) . As shown in Figure 4 , myogenin mRNA levels were readily detectable at 48 h in absence of RA-treatment in the three cell lines. However they were lowered in dominant-negative cells compared with the C2-neo cells, indicating a delay in the spontaneous differentiation process. In presence of RA, an earlier induction of myogenin occured in C2-neo cells (at 24 h) while this induction was reduced and delayed in dominantnegative C2 cells (Figure 4 ). Concerning MyoD, comparable basal level gene expression was observed in the three cell lines prior to RA-treatment. After addition of RA, the levels of MyoD induction are similar both in C2 control and C2-dnRAR1 cells. In contrast, in C2-dnRXR1 cells, RA failed to increase MyoD gene expression. These data were reproducibly observed with multiple preparations of RNA from dierent dominant-negative transfectants (C2-dnRAR2, C2-dnRXR2).
Thus, although the C2-dnRAR1 and C2-dnRXR1 cell populations behave in a similar fashion with respect to the RA-regulation of the RARb gene and the myogenin gene, they yet dier in RA-mediated regulation of MyoD gene. These results suggest that each RAR and RXR family may regulate dierent subsets of RA-responsive genes.
Evidence for a link between RXRa and MyoD
The above results led us to ask whether RXR and MyoD gene expressions are linked during the RAinduced myogenesis. To address this question, we exploited a C2 variant cell line, previously named Inducible', isolated and characterized by Pinset et al. (1988) . In opposition to parental C2 myoblasts, inducible myoblasts are not autonomous for differentiation and require insulin or IGFs to undergo terminal dierentiation (Pinset et al., 1988) . These two C2 cell lines dier also in their MyoD gene expression. When compared to progenitor C2 cells, inducible cells do not express the MyoD gene at the myoblast stage (Montarras et al., 1989) . However, overexpression of MyoD in this variant restores the C2 parental phenotype (Montarras et al., 1991) . Recently, we reported that, unlike parental C2 cells, inducible cells, renamed C2-R, are resistant to the RA myogenic eects and lack RXRa gene expression at the myoblast stage (FroeschleÂ et al., 1996) . Taken together, these observations led us to propose that RXRa and MyoD are linked and may be required for the RA-induction of myogenesis in C2 cell lines.
To address this issue, we compared the expression of RXRa in C2-R and C2-R/MyoD cells (a previously described C2-R cell line which constitutively express MyoD) (Montarras et al., 1991) Figure 5b , RA has no eect on the proliferation of C2-R cells while it inhibits the growth of C2-R/MyoD cells. To determine whether these RA-treated cells display a dierentiated phenotype, we carried out, under the same experimental conditions, immunu¯uorescence analysis using an antitroponin T antibody (Figure 5c ). After 4 days of RAtreatment, C2-R cells failed to depict any positive staining for troponin T. In contrast, C2-R/MyoD cells In conclusion, these results establish that forced expression of MyoD in C2-R myoblasts, which express neither MyoD nor RXRa and do not dierentiate upon RA treatment (Figure 5 and FroeschleÂ et al., 1996) , restores both expression of the RXRa gene and RA-induced dierentiation as in parental C2 cells.
Discussion
We are interested in exploring in detail the mechanisms by which RARs and RXRs might orchestrate the balance between growth and dierentiation in myogenesis. RARs and RXRs mediate most, if not all, of RA actions. C2 cells contain both RARs and RXRs, and thus the eects of RA on cellular dierentiation and proliferation may re¯ect activation of either RARs or RXRs or both. One way to examine the role of RARs and RXRs in myogenesis is to utilize dominant negative receptor constructs that would suppress normal RARs, RXRs function in myoblasts and then determine whether the expression of these constructs would alter the RA-control of growth and differentiation of these myoblasts. In this report, we have analysed the eects of RA in permanent C2 myoblast lines expressing a dominant negative RAR (dnRAR) lacking the ligand-dependent transcriptional activation function of RARa or a dominant negative RXR (dnRXR) lacking the DNA binding domain of RXRb. We show here that expression of these mutated receptors in C2 cells prevents several aspects of the RA-associated dierentiation pathway observed in C2 cells. Dominant negative receptors expression results in global alteration of RA-regulated growth and dierentiation in C2 cells, suggesting that retinoic acid receptors play a crucial role in the myogenic program. Our results reveal that the lack of RA action is always more substantial in C2-dnRXR than in C2-dnRAR cells. At the molecular level, the RA-impaired dierentiation is re¯ected by altered expression of the transcripts of several RA-responsive genes, including RARb, myogenin and MyoD. However, these mutated RA-receptors exhibit some functional speci®city, as the RA-inducible expression of the MyoD gene is inhibited in C2-dnRXR but not in C2-dnRAR cells. Thus, the present results strongly suggest that both RARs and RXRs are involved in RA-mediated dierentiation events; however they also suggest that the RXR family may play a major role in transducing the RA signal triggering C2 cell dierentiation.
The dominant negative activities described here are reminiscent of previously reported inhibitory eects seen in a number of normal or transformed cells from dierent tissues expressing truncated or otherwise mutated RA-receptors, or decreased levels of these receptors. Examples include a translocation breakpoint in RARa at the genetic lesion of acute promyelocytic leukemia ( The data from panel a were quanti®ed by densitometry and expressed relative to S26 mRNA levels which serve as control of RNA loading. This experiment was performed twice dominant negative RARa mutants in retinoid-resistant embryonic carcinoma lines (Pratt et al., 1990; Kruyt et al., 1992) , in RA-resistant HL-60 cells (Collins et al., 1990; Robertson et al., 1992) , expression of dominant negative RXRb mutant in P19 embryonal carcinoma cells (Minucci et al., 1994) , absence of RXRa expression in RA-resistant myogenic C2 cells (FroeschleÂ et al., 1996) and F9 embryonal carcinoma cells bearing single and compound RAR and RXR mutations (Boylan et al., 1993 (Boylan et al., , 1995 Cliord et al., 1996; Chiba et al., 1997) . Interestingly, in all these cases, proliferation characteristics and/or retinoidinduced dierentiation are altered. Therefore, the alteration of RA eects on the growth and differentiation of normal, embryonic and malignant cells is often associated with ± or even caused by ± an abrogation of RA-receptors expression and/or function.
RXRs are thought to exert pleiotropic functions, since besides their capacity to homodimerize, they are able to heterodimerize with multiple nuclear receptors (Chambon, 1994; GigueÁ re, 1994; Glass, 1994; Leblanc and Stunnenberg, 1995; Mangelsdorf and Evans, 1995) . In all cases, nuclei were stained with Hoechst B2883 dye. These experiments were carried out three times and yielded similar results Thereby, the dierent responsiveness to RA of the two types of dominant-negative C2 cell transfectants may involve other RXR partners. Possible candidates for such a partnership could be the orphan receptors, LXR (Willy et al., 1995) and NGF1-B-Nur77 or the closely related receptor NURR1 (Forman et al., 1995; Perlmann and Jansson, 1995) , which can heterodimerize with RXRs and confer RXR-speci®c ligand activation of transcription. It is thus conceivable that the RA treatment of C2 cells may activate such RXRdependent pathway. However this issue requires a thorough study concerning the role of these orphan receptors in muscle cell dierentiation. Whatever contributions by RXR-dependent pathways may exist, it is clear from the present study that the lack of RA action on myogenesis is much more substantial in C2-dnRXR than C2-dnRAR cells.
It is also possible that the dierent retinoid responsiveness between the two dominant negative receptor cell lines might rely on the RA regulation of their target genes expression. As shown in Figure 4 , these two cell lines do dier in the regulation of MyoD expression. Indeed, only C2-dnRXR cells were defective in RA-induced mRNA expression of MyoD. Hence, this could underlie some of the dierences in myogenic response to RA among these two types of cell lines. This possibility is supported by numerous observations which indicate a positive correlation between the level of MyoD gene expression and the ability of myogenic cell lines to terminally dierentiate (Pinset et al., 1988; Konieczny et al., 1989; Montarras et al., 1989 Montarras et al., , 1991 Tapscott et al., 1989; FroeschleÂ et al., 1996) . Thus, it appears that the impaired RA-induction of MyoD in C2-dnRXR cells could lead to a more severe C2 phenotype defective in RA-regulated growth and dierentiation. The molecular basis for this distinct response of MyoD to dnRAR and dnRXR is unknown but could be related to the presence of RXRE in this gene. Alternatively or concomitantly, the activity of MyoD protein could be dierentially modulated in these transfectants. In this respect, we have recently shown that RA-receptors interact with MyoD and upregulate its activity on skeletal muscle program. Interestingly, a dnRXRDDBD which did not interact with MyoD failed to potentiate MyoD transcriptional activity (our unpublished data).
MyoD has been implicated as a master regulatory gene in the process of muscle dierentiation: it is sucient to induce withdrawal from cell cycle and expression of muscle dierentiation markers (Crescenzi et al., 1989; Sorrentino et al., 1990; Weintraub et al., 1991) . These two myogenesis-related events are also regulated by retinoic acid suggesting that RA-receptors and MyoD might act in the same regulatory pathway governing the RA-induced myogenesis. Several lines of evidence support the notion that cooperation between the MyoD and RXR families is likely to play an important role in the process of myoblast differentiation: (i) We have shown here that only dnRXR is able to inhibit RA induction of MyoD expression and myogenesis, suggesting a speci®c role of RXR family in these events; (ii) The RXR receptor has already been suggested to be an integral component of the myogenic dierentiation pathway since we found that in RAresistant C2 cells (C2-R), susceptibility to RA-induced growth arrest could be restored by transfection of a RXRa expression vector (FroeschleÂ et al., 1996) . However, whether RXRa could induce RA-growth arrest, it could not activate the fully dierentiated program suggesting a lack of one or more mediators of dierentiation inducing activity of retinoic acid in this system. The myogenic factor MyoD which is absent at the myoblast stage in this cell line may be such a factor; (iii) A key ®nding in the present study has been the observation that overexpression of MyoD in this C2-resistant cell line restores the fully RA myogenic actions (i.e. the dierentiation and anti-proliferative eects of retinoids) but also induces the expression of RXRa gene. This suggests a special relationship betwen these two factors. There are several possible explanations, which are not mutually exclusive for this cooperative interaction. One is that there is a direct protein-protein interaction between RXRa and MyoD that increases the activity of either or both factors. This appears indeed to be the case since we recently established that members of the MyoD family and retinoic acid receptors are partners in retinoic acidinduced myogenesis and that this cooperativity is mediated by direct protein-protein interaction between (the DBD of) these heterologous classes of transcription factors. Another possibility is that, as a transcription factor, MyoD participates directly or indirectly in the control of RXRa gene expression. However, this issue must await the identi®cation of RXRa regulatory sequences. Taken together, these data strongly suggest that coexpression of MyoD and RXRa could lead to RA-induced muscle differentiation.
It should be noted that growing evidences in the literature underscore the role of RXRs in the mediation of the developmental retinoid signal in vivo. Indeed, the recent phenotypic characterization of all combinations of RXR (either a, b or g)/RAR (either a, b or g) compound mutants has provided genetic evidence supporting the proposal that RXR-RAR heterodimers act as functional units transducing the retinoid signal in vivo and furthermore has indicated that RXRa is the functionally predominant RXR in vivo (Kastner et al., , 1996a . In addition, it has been shown that RXRa null mutants are resistant to RA-induced limb defects (Sucov et al., 1995) . Taken together, these data reveal the importance of RXRa as an integral component of the RA signalling cascade in vivo. However, the question about the role of RXRs and in particular RXRa in the transduction of the RA signal during muscle development remains.
Retinoic acid is an important signaling molecule in embryonic development (Tabin, 1991) and several evidences suggest a role for RA in the determination of the muscle lineage (Chen and Solursh, 1991; Sive and Cheng, 1991) . This is supported by the presence of retinoids in myogenic precursor cells (Wagner et al., 1990 (Wagner et al., , 1992 Chen et al., 1992) and RA-receptors in muscle tissue DolleÂ et al., 1994; GigueÁ re, 1994) . However, the knock-outs of RARs and RXRs in the mouse to date did not compromise skeletal muscle development (Kastner et al., , 1996b Sucov et al., 1994; Lohnes et al., 1995; Krezel et al., 1996) probably due to a large degree of functional redundancy among these receptors which prevented a de®nitive assignment of their physiological functions in the animal. To disable completely the retinoid pathway in skeletal muscle, it will be necessary to generate multiple knock-outs of RARs and RXRs. Alternatively, the targeted expression of a dominant negative retinoic acid-receptor in transgenic mice allows to investigate the stage-and organ-speci®c roles of retinoids in mammalian development. This latter approach was used with success to evaluate the role of retinoids in epidermal development (Imakado et al., 1995; Saitou et al., 1995) . In this study we have described the eects of two dominant negative RAreceptors which are capable of inhibiting wild type receptor function in C2 myogenic cells. Targeted expression of these dominant negative mutants in the muscle of transgenic mice will be helpful to evaluate the function of retinoids and RA-receptors during cell dierentiation and embryonic development of this tissue.
Materials and methods

Cell culture products
Dulbecco's modi®ed Eagle's medium (DMEM), nutrient mixture F-12 (Ham), Fetal Calf Serum (FCS) and Geneticin (G-418) were purchases from Gibco-BRL. Alltrans retinoic acid (RA) was obtained from Sigma. Alltrans RA was diluted in dimethyl sulfoxide (DMSO) whereas G418 was diluted in PBS.
Cell culture conditions
Permissive C2.7, inducible myoblasts (designated C2-R in this study) and inducible cells stably transfected with the mouse MyoD cDNA (C2-R/MyoD) have been previously described (Pinset et al., 1988; Montarras et al., 1991) . Proliferating myoblasts were routinely maintained in proliferation medium (1 : 1 mixture of DMEM and HamF-12 supplemented with 10% FCS) and incubated at 378C under 5% CO 2 . Before any treatment with all-trans RA, cells were grown for about 7 days in proliferation medium containing 10% hormone-depleted FCS. Depleted serum was obtained using the resin procedure of Samuels et al. (1979) . All RA-treatments were performed 48 h after plating at a density of 2610 3 cells/cm 2 . For dierentiation, cells were plated at a density of 4610 3 cells/cm 2 , grown for 3 days in proliferation medium containing 10% hormonedepleted FCS and then transferred into dierentiation medium (DMEM supplemented with 2% hormonedepleted FCS). RA or solvent (0.1% DMSO) were added simultaneously to the medium change.
Stable transfection of C2 cells with dnRAR or dnRXR expressing vectors
C2 cells were co-transfected using DOTAP reagent (Boehringer) as described by the supplier with DNA from pSG5 vectors containing or lacking the murine dnRAR or dnRXR coding sequence Minucci et al., 1994) and pSV2neo DNA carrying the neomycin marker. For each transfection, 10 mg of the dnRAR or dnRXR expression vector and 500 ng of the pSV2neo (molar ratio was 20 : 1) were used. The transfected cells were selected in the presence of 1 mg/ml G-418 (Geneticin, Gibco-BRL) for 10 ± 15 days. Individual colonies (10 ± 12) were isolated then passaged into stable cell lines. Expression of dnRAR and dnRXR in these cell populations was analysed by Northern blotting. C2 cells transfected by pSV2neo and pSG5 (C2-neo cells) were also selected and used as control cells.
Colony formation assay
C2 cells (10 5 cells) seeded in a 100-mm-diameter dish were cotransfected with 200 ng of pSV2neo and 10 mg of the expression vector (either pSG5-dnRAR, pSG5-dnRXR, or pSG5 without insert) for 24 h and were then immediately exposed to G418 (1 mg/ml). After 24 ± 36 h, all-trans RA (1 mM) was added to half of the culture. Cells were fed with fresh G418 and RA every 2 ± 3 days for up to 2 weeks, until macroscopic colonies developed. Plates were ®xed with methanol and stained with Giemsa stain (Sigma) and the number of colonies was counted.
RNA extraction and Northern blot analysis
Total RNA was prepared using guanidinium thyocyanate as previously described (Chomczynski et al., 1987) . When needed, poly(A) + RNA was puri®ed on oligo(dT) cellulose (Pharmacia). For Northern blot analysis, total RNA (20 mg) and poly(A) + RNA (corresponding to 200 mg total RNA) were run on a 2 M formaldehyde-containing 1% agarose gel, transferred and bound to nylon membranes (Hybond, Amersham) as described by the supplier. Filters were prehybridized and hybridized in a mixture containing 50% formamide, 5 mM NaPO 4 , 0.75 M NaCl, 1 mM EDTA, 0.5% sodium dodecyl sulfate (SDS), 0.4 mg/ml denaturated DNA salmon sperm, 106Denhardt solution, 1% dextran sulfate and the appropriated probe (10 6 c.p.m./ml) at 428C and washed twice (30 min each) in 0.26 standard saline citrate (SSC)/0.1% SDS at 658C. Filters were hybridized using the following cDNA probes labeled by random priming: mouse RAR a, b and RXR a, b (Zelent et al., 1989) , mouse MyoD (Davis et al., 1987) , mouse myogenin (Edmondson et al., 1989) and hamster ribosomal S26 protein . Radioactivity on the nylon membranes was determined on a PhosphorImager analyser.
Transient transfections and CAT assays
C2 cells were plated at a density of 7610 3 cells/cm 2 (in 60 mm plate) in proliferation medium supplemented with 10% hormone-depleted serum. After 16 h, transfections of plasmid DNA were performed using DOTAP reagent (Boehringer) as described by the supplier. Brie¯y, cells were transfected with 1 mg of reporter construct (RAREbtk-CAT), 2 mg of b-galactosidase expression vector (PCH110-Pharmacia) and 1 mg of receptor expression vectors (either pSG5-dnRAR or pSG5-dnRXR) or the parental expression vector pSG5 (see Figure legend) . Transfection mixtures were always adjusted to 4 mg of DNA per plate. Cells were exposed to the DNA for 8 h then refed with DMEM/HamF-12 medium supplemented with 10% depleted FCS. RA treatment (10 76 M) was performed 24 h after transfection. Determination of CAT activity was performed as previously described . The b-galactosidase activity was measured as previously described (Nilsen et al., 1983) to normalize for transfection eciency.
The reporter construct RAREb-tk-CAT has been previously described by Durand et al. (1992) .
Immuno¯uorescence
Cells were grown for 96 h in proliferation medium, then shifted in dierentiation medium and treated or not with RA (see above). After 72 h, cells were ®xed for 5 min in 3.7% (wt/vol) formaldehyde in PBS followed by a 30 s extraction in 7208C acetone. Expression of troponin T was assayed using 1 h incubation of cells with a mouse monoclonal antibody against troponin T diluted 1 : 100 (Sigma). Cells were stained with Hoechst B2883 dye and mounted in Airvol 205 (15% Airvol 205, Air Products, Utrecht, the Netherlands, 33% glycerol, 0.1% NaN 3 in PBS, pH7). Stained cells were observed under microscope (Axiophot, Carl Zeiss, Inc., Thornwood, NY) using a planapochromat 406 objective. Fluorescent images were recorded onto TMAX 400 ®lm (Eastman Kodak Co., Rochester, NY).
[
H]thymidine incorporation assays
To assay the eect of RA on proliferation, cells were grown in proliferation medium. The ®rst RA-treatment (10 76 M) was performed a few hours after plating and then RA was daily pulsed into medium. At daily intervals (17 h after hormonal treatment), transfected cells were pulsed for 8 h with 2 mCi/ml [ 3 H]thymidine (ICN, France, speci®c activity 5 Ci/mmol). At the end of labelling period, transfected cells were rinsed three times with ice-cold PBS followed by the addition of 2 ml of 5% ice-cold trichloroacetic acid (TCA), in which the cells were maintained 10 min. Cells were then rinsed three times with ethanol 90% and dissolved in 1 ml of 0.1 N NaOH at 378C for 1 h. NaOH suspensions were transferred into scintillation vials. Radioactivity was measured using 10 ml liquid scintillation PCS II (Amersham, France).
